Clinical Trial Update: A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating AVE8112 in Parkinson's disease was terminated; the trial assessed safety, tolerability, pharmacokinetics, and pharmacodynamics in a m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AVE8112

Snippet

Sponsor: Michael J. Fox Foundation for Parkinson's Research | Conditions: Parkinson's Disease | Phase 1 | Status: TERMINATED